Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT

Conditions:   Malignant Neoplasm of Breast;   Malignant Neoplasms of Digestive Organs;   Malignant Neoplasms of Eye Brain and Other Parts of Central Nervous System;   Malignant Neoplasms of Female Genital Organs;   Malignant Neoplasms of Ill-defined Secondary and Unspecified Sites;   Malignant Neoplasms of Independent (Primary) Multiple Sites;   Malignant Neoplasms of Lip Oral Cavity and Pharynx;   Malignant Neoplasms of Male Genital Organs;   Malignant Neoplasms of Mesothelial and Soft Tissue;   Malignant Neoplasms of Respiratory and Intrathoracic Organs;   Malignant Neoplasms of Thyroid and Other Endocrine Glands;   Malignant Neoplasms of Urinary Tract
Interventions:   Drug: Pembrolizumab;   Biological: Clostridium Novyi-NT;   Drug: Doxycycline
Sponsors:   M.D. Anderson Cancer Center;   BioMed Valley Discoveries, Inc;   Merck Sharp & Dohme Corp.
Not yet recruiting

http://ift.tt/2FbLoHX